Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash-to-Debt No Debt
PETS's Cash-to-Debt is ranked higher than
99% of the 360 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.53 vs. PETS: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
PETS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.11  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.83
PETS's Equity-to-Asset is ranked higher than
98% of the 361 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.42 vs. PETS: 0.83 )
Ranked among companies with meaningful Equity-to-Asset only.
PETS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17  Med: 0.88 Max: 0.93
Current: 0.83
0.17
0.93
Interest Coverage No Debt
PETS's Interest Coverage is ranked higher than
99% of the 320 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.24 vs. PETS: No Debt )
Ranked among companies with meaningful Interest Coverage only.
PETS' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 5
Altman Z-Score: 27.65
Beneish M-Score: -4.00
WACC vs ROIC
4.03%
58.92%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 15.04
PETS's Operating Margin % is ranked higher than
94% of the 361 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.05 vs. PETS: 15.04 )
Ranked among companies with meaningful Operating Margin % only.
PETS' s Operating Margin % Range Over the Past 10 Years
Min: 10.92  Med: 14.03 Max: 17.02
Current: 15.04
10.92
17.02
Net Margin % 9.56
PETS's Net Margin % is ranked higher than
93% of the 362 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.78 vs. PETS: 9.56 )
Ranked among companies with meaningful Net Margin % only.
PETS' s Net Margin % Range Over the Past 10 Years
Min: 6.99  Med: 8.89 Max: 10.91
Current: 9.56
6.99
10.91
ROE % 27.05
PETS's ROE % is ranked higher than
90% of the 354 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.67 vs. PETS: 27.05 )
Ranked among companies with meaningful ROE % only.
PETS' s ROE % Range Over the Past 10 Years
Min: 18.7  Med: 26.36 Max: 33.12
Current: 27.05
18.7
33.12
ROA % 23.96
PETS's ROA % is ranked higher than
98% of the 364 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.31 vs. PETS: 23.96 )
Ranked among companies with meaningful ROA % only.
PETS' s ROA % Range Over the Past 10 Years
Min: 16.88  Med: 23.59 Max: 29.73
Current: 23.96
16.88
29.73
ROC (Joel Greenblatt) % 96.30
PETS's ROC (Joel Greenblatt) % is ranked higher than
96% of the 363 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.45 vs. PETS: 96.30 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PETS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 91.28  Med: 106.27 Max: 194.27
Current: 96.3
91.28
194.27
3-Year Revenue Growth Rate 1.60
PETS's 3-Year Revenue Growth Rate is ranked lower than
70% of the 318 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. PETS: 1.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PETS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -0.3  Med: 9.7 Max: 58
Current: 1.6
-0.3
58
3-Year EBITDA Growth Rate 9.50
PETS's 3-Year EBITDA Growth Rate is ranked lower than
52% of the 285 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.20 vs. PETS: 9.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
PETS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -8.7  Med: 9.5 Max: 106.3
Current: 9.5
-8.7
106.3
3-Year EPS without NRI Growth Rate 9.10
PETS's 3-Year EPS without NRI Growth Rate is ranked higher than
51% of the 252 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.30 vs. PETS: 9.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
PETS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -9  Med: 9.1 Max: 104.1
Current: 9.1
-9
104.1
GuruFocus has detected 6 Warning Signs with PetMed Express Inc $PETS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PETS's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

PETS Guru Trades in Q2 2016

Paul Tudor Jones 18,400 sh (New)
Jim Simons 1,662,315 sh (+2.96%)
Chuck Royce 401,500 sh (unchged)
Barrow, Hanley, Mewhinney & Strauss Sold Out
Joel Greenblatt Sold Out
Ken Fisher 148,049 sh (-20.88%)
John Buckingham 102,012 sh (-28.37%)
» More
Q3 2016

PETS Guru Trades in Q3 2016

Chuck Royce 401,500 sh (unchged)
Paul Tudor Jones Sold Out
John Buckingham 100,190 sh (-1.79%)
Jim Simons 1,567,915 sh (-5.68%)
Ken Fisher 115,453 sh (-22.02%)
» More
Q4 2016

PETS Guru Trades in Q4 2016

Jim Simons 1,597,700 sh (+1.90%)
John Buckingham 96,699 sh (-3.48%)
Chuck Royce 309,600 sh (-22.89%)
Ken Fisher 60,164 sh (-47.89%)
» More
Q1 2017

PETS Guru Trades in Q1 2017

Ken Fisher 86,359 sh (+43.54%)
Jim Simons 1,786,315 sh (+11.81%)
John Buckingham 97,720 sh (+1.06%)
Chuck Royce 309,600 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with PETS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers    NAICS: 541940    SIC: 5912
Compare:NYSE:GNC, OTCBB:COCP, NAS:CJJD, OTCPK:OMHE, OTCPK:HEWA, OTCPK:CLCGY, NYSE:RAD, OTCPK:RADLY, NAS:WBA » details
Traded in other countries:PQM.Germany,
Headquarter Location:USA
PetMed Express Inc is a nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs, cats, and horses direct to the consumer.

PetMed Express Inc was incorporated in the state of Florida in January 1996. The Company is a nationwide pet pharmacy. It markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. It markets its products through national television, online, and direct mail/print advertising campaigns, which aim to increase the recognition of the "1-800-PetMeds" brand name and "PetMeds". It offers a selection of products for dogs and cats. Its current product line contains approximately 3,000 SKUs of the popular pet medications, health products, and supplies. These products include a majority of the brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution, and Rimadyl. The Company offers its products through three main sales channels: Internet through its website, telephone contact center through its toll-free number, and direct mail/print through 1-800-PetMeds catalogs, brochures, and postcards. It have designed its website and catalogs to provide a convenient, cost-effective, and informative shopping experience that encourages consumers to purchase products important for a pet's health and quality of life. Its customers are located throughout the United States, with approximately 50% of customers residing in California, Florida, New York, Texas, Pennsylvania, Virginia, North Carolina, and New Jersey. Its primary focus has been on retail customers. Its competitors consist of veterinarians, and online and traditional retailers. Its trademarks include PetMed Express and Design, 1888PetMeds and Design, 1-800-PetMeds and Design, 1-800-PetMeds, and PetMeds. The Company is subject to regulation by the State of Florida and is licensed as a community pharmacy by the Florida Board of Pharmacy.

Top Ranked Articles about PetMed Express Inc

PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 8, 2017
AmsterDog Rescue to Ring The Nasdaq Stock Market Opening Bell in Celebration of National Puppy Day
ADVISORY, March 22, 2017 (GLOBE NEWSWIRE) --
What:
AmsterDog Rescue will visit the Nasdaq MarketSite in Times Square in celebration of National Puppy Day on March 23, 2017. AmsterDog Rescue is supported by PetMed Express, Inc. (NASDAQ:PETS).In honor of the occasion, Deborah DiIorio, Founder, will ring the Opening Bell. Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast StudioWhen:
Thursday, March 23, 2017 – 9:15 a.m. to 9:30 a.m. ET    AmsterDog Media Contact:
Alyson Balan-Altman
732 604 0625
[email protected]Nasdaq MarketSite:
Emily Pan
(646) 441-5120
[email protected]Feed Information:
Fiber Line (Encompass Waterfront): 4463Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSKSocial Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page:
http://www.facebook.com/NASDAQ.For photos from ceremonies and events, please visit our Instagram page:
http://instagram.com/nasdaqFor livestream of ceremonies and events, please visit our YouTube page:
http://www.youtube.com/nasdaq/liveFor news tweets, please visit our Twitter page:
http://twitter.com/nasdaqFor exciting viral content and ceremony photos, please visit our Tumblr page:
http://nasdaq.tumblr.com/Webcast:
A live stream of the Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asxPhotos:
To obtain a hi-resolution photograph of the Market Open, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your choice.          About AmsterDog Dog Rescue
AmsterDog Rescue began in seed after a small group of volunteers got together to help animals in need in New Orleans after Hurricane Katrina. We did fundraising, went down to rescue dogs and brought several vanloads of homeless pets up to the northeast and found them forever homes. In the process of that rewarding endeavor, we became aware of how many sweet adoptable dogs and cats were being put down every day right here in our own city shelters.With a desire to help save these precious lives, we formed a small rescue effort and became an established group in May 2010 called AmsterDog Rescue, named after our beloved dog named Amsterdam, found on the Ave he was named for. Amsterdam was found wandering the streets of Harlem, a big white 70 lb. scary looking Pit Bull mix, and many people would cross the street when they saw him. In fact, he is a big mush of a dog, loves to nuzzle, get belly rubs and keeps us all calm. He is our rock and truly is proof that they, in fact, rescue us!We are a non-profit group of volunteers. AmsterDog is a 501c3 organization and all donations go solely to help saving more animals in need. We are dedicated to the plight of abandoned animals, finding loving, responsible homes for animals on death-row, with special focus on the abused animals, who find themselves in city shelters, through no fault of their own.About PetMeds® 
Founded in 1996, Petmeds.com is America's Largest Pet Pharmacy and Vet-VIPPS accredited, delivering prescription and non-prescription medications, and pet supplies for less, direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website.About Nasdaq
Nasdaq (NASDAQ:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables clients to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 85 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,800 listed companies with a market value of $10.1 trillion and nearly 18,000 corporate clients. To learn more, visit: business.nasdaq.com.-NDAQA-


Read more...

Ratios

vs
industry
vs
history
PE Ratio 29.49
PETS's PE Ratio is ranked higher than
54% of the 301 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.20 vs. PETS: 29.49 )
Ranked among companies with meaningful PE Ratio only.
PETS' s PE Ratio Range Over the Past 10 Years
Min: 11.34  Med: 16.59 Max: 30.47
Current: 29.49
11.34
30.47
Forward PE Ratio 29.85
PETS's Forward PE Ratio is ranked lower than
60% of the 172 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 16.81 vs. PETS: 29.85 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 29.49
PETS's PE Ratio without NRI is ranked higher than
55% of the 290 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.78 vs. PETS: 29.49 )
Ranked among companies with meaningful PE Ratio without NRI only.
PETS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.34  Med: 16.59 Max: 30.47
Current: 29.49
11.34
30.47
Price-to-Owner-Earnings 18.15
PETS's Price-to-Owner-Earnings is ranked higher than
51% of the 202 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 19.55 vs. PETS: 18.15 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
PETS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.6  Med: 18.71 Max: 49.49
Current: 18.15
8.6
49.49
PB Ratio 7.60
PETS's PB Ratio is ranked lower than
85% of the 361 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.81 vs. PETS: 7.60 )
Ranked among companies with meaningful PB Ratio only.
PETS' s PB Ratio Range Over the Past 10 Years
Min: 2.33  Med: 4.32 Max: 7.84
Current: 7.6
2.33
7.84
PS Ratio 2.83
PETS's PS Ratio is ranked lower than
88% of the 358 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.47 vs. PETS: 2.83 )
Ranked among companies with meaningful PS Ratio only.
PETS' s PS Ratio Range Over the Past 10 Years
Min: 0.84  Med: 1.53 Max: 2.92
Current: 2.83
0.84
2.92
Price-to-Free-Cash-Flow 19.20
PETS's Price-to-Free-Cash-Flow is ranked lower than
100% of the 154 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.18 vs. PETS: 19.20 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PETS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.83  Med: 17.74 Max: 2097.27
Current: 19.2
7.83
2097.27
Price-to-Operating-Cash-Flow 14.92
PETS's Price-to-Operating-Cash-Flow is ranked lower than
67% of the 198 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.59 vs. PETS: 14.92 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PETS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.65  Med: 15.76 Max: 36.37
Current: 14.92
7.65
36.37
EV-to-EBIT 17.36
PETS's EV-to-EBIT is ranked higher than
77% of the 441 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.48 vs. PETS: 17.36 )
Ranked among companies with meaningful EV-to-EBIT only.
PETS' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.7  Med: 9.2 Max: 17.91
Current: 17.36
4.7
17.91
EV-to-EBITDA 16.75
PETS's EV-to-EBITDA is ranked higher than
57% of the 453 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.29 vs. PETS: 16.75 )
Ranked among companies with meaningful EV-to-EBITDA only.
PETS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.5  Med: 8.9 Max: 17.28
Current: 16.75
4.5
17.28
PEG Ratio 4.55
PETS's PEG Ratio is ranked lower than
87% of the 170 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.20 vs. PETS: 4.55 )
Ranked among companies with meaningful PEG Ratio only.
PETS' s PEG Ratio Range Over the Past 10 Years
Min: 0.33  Med: 0.71 Max: 94
Current: 4.55
0.33
94
Shiller PE Ratio 33.81
PETS's Shiller PE Ratio is ranked higher than
61% of the 76 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 23.50 vs. PETS: 33.81 )
Ranked among companies with meaningful Shiller PE Ratio only.
PETS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.11  Med: 18.02 Max: 50.21
Current: 33.81
13.11
50.21
Current Ratio 4.46
PETS's Current Ratio is ranked higher than
98% of the 345 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.21 vs. PETS: 4.46 )
Ranked among companies with meaningful Current Ratio only.
PETS' s Current Ratio Range Over the Past 10 Years
Min: 0.33  Med: 7.76 Max: 12.2
Current: 4.46
0.33
12.2
Quick Ratio 3.35
PETS's Quick Ratio is ranked higher than
97% of the 345 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.75 vs. PETS: 3.35 )
Ranked among companies with meaningful Quick Ratio only.
PETS' s Quick Ratio Range Over the Past 10 Years
Min: 0.16  Med: 4.5 Max: 8.1
Current: 3.35
0.16
8.1
Days Inventory 44.09
PETS's Days Inventory is ranked lower than
58% of the 350 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 39.37 vs. PETS: 44.09 )
Ranked among companies with meaningful Days Inventory only.
PETS' s Days Inventory Range Over the Past 10 Years
Min: 44.09  Med: 63.9 Max: 78.88
Current: 44.09
44.09
78.88
Days Sales Outstanding 2.65
PETS's Days Sales Outstanding is ranked higher than
87% of the 268 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.41 vs. PETS: 2.65 )
Ranked among companies with meaningful Days Sales Outstanding only.
PETS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.31  Med: 2.9 Max: 4.79
Current: 2.65
2.31
4.79
Days Payable 32.71
PETS's Days Payable is ranked lower than
92% of the 264 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 48.66 vs. PETS: 32.71 )
Ranked among companies with meaningful Days Payable only.
PETS' s Days Payable Range Over the Past 10 Years
Min: 11.53  Med: 13.73 Max: 32.71
Current: 32.71
11.53
32.71

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.26
PETS's Dividend Yield % is ranked higher than
80% of the 474 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.99 vs. PETS: 2.26 )
Ranked among companies with meaningful Dividend Yield % only.
PETS' s Dividend Yield % Range Over the Past 10 Years
Min: 0.51  Med: 4.12 Max: 5.85
Current: 2.26
0.51
5.85
Dividend Payout Ratio 0.70
PETS's Dividend Payout Ratio is ranked higher than
50% of the 290 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.70 vs. PETS: 0.70 )
Ranked among companies with meaningful Dividend Payout Ratio only.
PETS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.68 Max: 0.78
Current: 0.7
0.26
0.78
3-Year Dividend Growth Rate 4.80
PETS's 3-Year Dividend Growth Rate is ranked lower than
53% of the 178 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.40 vs. PETS: 4.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
PETS' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 26
Current: 4.8
0
26
Forward Dividend Yield % 2.29
PETS's Forward Dividend Yield % is ranked higher than
81% of the 453 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.08 vs. PETS: 2.29 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.20
PETS's 5-Year Yield-on-Cost % is ranked higher than
78% of the 505 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.97 vs. PETS: 3.20 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
PETS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.72  Med: 5.83 Max: 8.28
Current: 3.2
0.72
8.28
3-Year Average Share Buyback Ratio -0.60
PETS's 3-Year Average Share Buyback Ratio is ranked higher than
53% of the 196 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.70 vs. PETS: -0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PETS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -45.6  Med: -0.4 Max: 4.5
Current: -0.6
-45.6
4.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 17.94
PETS's Price-to-Net-Cash is ranked higher than
54% of the 26 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.74 vs. PETS: 17.94 )
Ranked among companies with meaningful Price-to-Net-Cash only.
PETS' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 5.34  Med: 11.07 Max: 23.38
Current: 17.94
5.34
23.38
Price-to-Net-Current-Asset-Value 11.27
PETS's Price-to-Net-Current-Asset-Value is ranked lower than
55% of the 119 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.79 vs. PETS: 11.27 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
PETS' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.24  Med: 6.44 Max: 40
Current: 11.27
3.24
40
Price-to-Tangible-Book 7.60
PETS's Price-to-Tangible-Book is ranked lower than
77% of the 313 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.07 vs. PETS: 7.60 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
PETS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.14  Med: 5.31 Max: 20.43
Current: 7.6
3.14
20.43
Price-to-Intrinsic-Value-Projected-FCF 2.73
PETS's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
62% of the 207 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.48 vs. PETS: 2.73 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PETS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.8  Med: 1.46 Max: 5.96
Current: 2.73
0.8
5.96
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.74
PETS's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
99.99% of the 58 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.36 vs. PETS: 2.74 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.83
PETS's Price-to-Median-PS-Value is ranked higher than
53% of the 302 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.11 vs. PETS: 1.83 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PETS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.3  Med: 0.97 Max: 2.02
Current: 1.83
0.3
2.02
Price-to-Peter-Lynch-Fair-Value 4.61
PETS's Price-to-Peter-Lynch-Fair-Value is ranked lower than
82% of the 95 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.63 vs. PETS: 4.61 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
PETS' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.55  Med: 0.79 Max: 4.75
Current: 4.61
0.55
4.75
Price-to-Graham-Number 3.15
PETS's Price-to-Graham-Number is ranked lower than
68% of the 241 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.48 vs. PETS: 3.15 )
Ranked among companies with meaningful Price-to-Graham-Number only.
PETS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.47  Med: 1.97 Max: 5.88
Current: 3.15
1.47
5.88
Earnings Yield (Greenblatt) % 5.75
PETS's Earnings Yield (Greenblatt) % is ranked higher than
79% of the 488 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.09 vs. PETS: 5.75 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PETS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.59  Med: 10.9 Max: 21.2
Current: 5.75
5.59
21.2
Forward Rate of Return (Yacktman) % 9.03
PETS's Forward Rate of Return (Yacktman) % is ranked higher than
58% of the 234 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.25 vs. PETS: 9.03 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
PETS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1.2  Med: 15.3 Max: 65.7
Current: 9.03
1.2
65.7

More Statistics

Revenue (TTM) (Mil) $249.2
EPS (TTM) $ 1.17
Beta0.30
Short Percentage of Float20.35%
52-Week Range $17.70 - 35.88
Shares Outstanding (Mil)20.53

Analyst Estimate

Mar18 Mar19
Revenue (Mil $)
EPS ($) 1.17 1.28
EPS without NRI ($) 1.17 1.28
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for PETS

Headlines

Articles On GuruFocus.com
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 8, 2017 May 01 2017 
AmsterDog Rescue to Ring The Nasdaq Stock Market Opening Bell in Celebration of National Puppy Day Mar 22 2017 
Own These Four Dividend Stocks Instead of a Condo Nov 04 2015 
10 High-Yielding Small Caps For A Portfolio Return Boost Apr 23 2015 
Bob Olstein Says Forget Amazon, Buy PetSmart, Teradata Jun 13 2014 
PetMed Express Inc. Is Trying Harder to Push Sales Apr 21 2014 
4 Cash Gushing, Undervalued Small Cap Stocks With Zero Debt Apr 08 2014 
4 Biggest Dividend Challengers with Low Debt and Nice Initial Yields Aug 28 2013 
12 Dividend Stocks Sending More Cash to Shareholders Aug 05 2013 
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 

More From Other Websites
PetMed Express, Inc. : PETS-US: Dividend Analysis : May 19th, 2017 (record date) : By the numbers :... May 19 2017
2 Top Dividend Stocks That Could Double May 15 2017
Edited Transcript of PETS earnings conference call or presentation 8-May-17 12:30pm GMT May 12 2017
Zacks.com featured highlights: GATX, Lazard, PetMed Express, MKS Instruments and Lear May 12 2017
PetMed Express, Inc.: Leads amongst peers with strong fundamentals May 09 2017
PetMed (PETS) Beats Earnings, Revenue Estimates in Q4 May 09 2017
Investors Loving This Stock Like People Love Their Pets May 09 2017
Why Petmed Express Inc's Shares Popped 26% Today May 08 2017
PetMed beats Street 4Q forecasts May 08 2017
PetMed Express, Inc. D/B/A 1-800-PETMEDS Announces Its Financial Results for Fiscal 2017 and Its... May 08 2017
Investor Network: PETMED EXPRESS INC. to Host Earnings Call May 08 2017
Blog Coverage Alkermes Announces Completion of Patient Enrolment in ALKS 3831 Study for the... May 02 2017
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 8, 2017 May 01 2017
PetMed Faces Concerns over New Order Sales, Competition Apr 07 2017
Blog Coverage Valeant's Bausch + Lomb Receives FDA Clearance for Vision Enhancement System Apr 07 2017
PetMed Express, Inc. breached its 50 day moving average in a Bearish Manner : PETS-US : April 5,... Apr 05 2017
PetMed Express' New Order Sales Disappoint, Competition Rife Mar 24 2017
AmsterDog Rescue to Ring The Nasdaq Stock Market Opening Bell in Celebration of National Puppy Day Mar 22 2017
PetMed Express, Inc. : PETS-US: Dividend Analysis : February 06th, 2017 (record date) : By the... Mar 21 2017
PetMed (PETS) Lags Q3 Earnings Estimates, Tops Revenues Jan 26 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat